Cargando…
Outcome of Rapamycin Therapy for Post-Transplant-Lymphoproliferative Disorder after Kidney Transplantation: Case Series
BACKGROUND: Post-transplant lymphoproliferative disorders (PTLD) are a complication of chronic immunosuppressive therapy in solid organ transplantation with a high mortality rate. Alternative treatments such as rapamycin have been explored. METHODS: A detailed retrospective analysis was performed ac...
Autores principales: | Ashrafi, Farzaneh, Shahidi, Shahrzad, Ebrahimi, Zeinab, Mortazavi, Mojgan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369231/ https://www.ncbi.nlm.nih.gov/pubmed/25802698 |
Ejemplares similares
-
Survival of Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation in Patients under Rapamycin Treatment
por: Ashrafi, Farzaneh, et al.
Publicado: (2021) -
Ocular post-transplant lymphoproliferative disorder
por: Chen, Yun-Wen, et al.
Publicado: (2015) -
Management of post-transplant lymphoproliferative disorders
por: Dierickx, Daan, et al.
Publicado: (2019) -
Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
por: Asleh, Rabea, et al.
Publicado: (2022) -
Post transplant lymphoproliferative disorder: a case series and review of literature
por: Cader, Rizna Abdul, et al.
Publicado: (2013)